Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ARI Treatment Use and Outcomes in Non-metastatic Prostate Cancer (nmPC) Patients in the US

NCT06204302 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT06204302
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06204302 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ARI Treatment Use and Outcomes in Non-metastatic Prostate Cancer (nmPC) Patients in the US
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
January 5, 2024
Completion date
April 4, 2024
Enrollment
1,800 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-metastatic castration-resistant prostate cancer, non-metastatic prostate cancer